These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 29956369)
21. Parasympathomimetic drugs for the treatment of salivary gland dysfunction due to radiotherapy. Davies AN; Thompson J Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD003782. PubMed ID: 26436597 [TBL] [Abstract][Full Text] [Related]
22. Artificial saliva products and drugs to treat xerostomia. Wynn RL; Meiller TF Gen Dent; 2000; 48(6):630-6. PubMed ID: 12004654 [No Abstract] [Full Text] [Related]
23. A new medication for treatment of dry mouth in Sjögren's syndrome. al-Hashimi I; Taylor SE Tex Dent J; 2001 Apr; 118(3):262-6. PubMed ID: 11404944 [TBL] [Abstract][Full Text] [Related]
24. Effect of cevimeline on radiation-induced salivary gland dysfunction and AQP5 in submandibular gland in mice. Takakura K; Takaki S; Takeda I; Hanaue N; Kizu Y; Tonogi M; Yamane GY Bull Tokyo Dent Coll; 2007 May; 48(2):47-56. PubMed ID: 17978545 [TBL] [Abstract][Full Text] [Related]
25. [Clinical significance of cevimeline hydrochloride in the treatment of dry mouth in patients with Sjögren's syndrome]. Ogawa N; Shimoyama K; Karasawa H; Fukushima T; Masaki Y; Wano Y; Hirose Y; Sugai S Nihon Rinsho Meneki Gakkai Kaishi; 2004 Oct; 27(5):330-7. PubMed ID: 15559322 [TBL] [Abstract][Full Text] [Related]
27. Interventions for dry mouth and hyposalivation in Sjögren's syndrome: A systematic review and meta-analysis. Al Hamad A; Lodi G; Porter S; Fedele S; Mercadante V Oral Dis; 2019 May; 25(4):1027-1047. PubMed ID: 30086205 [TBL] [Abstract][Full Text] [Related]
28. Radiation-induced xerostomia: how dry is your patient? Bruce SD Clin J Oncol Nurs; 2004 Feb; 8(1):61-7. PubMed ID: 14983765 [TBL] [Abstract][Full Text] [Related]
29. Effectiveness of cevimeline to improve oral health in patients with postradiation xerostomia. Witsell DL; Stinnett S; Chambers MS Head Neck; 2012 Aug; 34(8):1136-42. PubMed ID: 22231734 [TBL] [Abstract][Full Text] [Related]
30. Salivary enhancement: current status and future therapies. Atkinson JC; Baum BJ J Dent Educ; 2001 Oct; 65(10):1096-101. PubMed ID: 11699983 [TBL] [Abstract][Full Text] [Related]
31. Pilocarpine treatment of xerostomia in head and neck patients. Leek H; Albertsson M Micron; 2002; 33(2):153-5. PubMed ID: 11567884 [TBL] [Abstract][Full Text] [Related]
32. Effect of cevimeline on salivary components in patients with Sjögren syndrome. Suzuki K; Matsumoto M; Nakashima M; Takada K; Nakanishi T; Okada M; Ohsuzu F Pharmacology; 2005 May; 74(2):100-5. PubMed ID: 15722648 [TBL] [Abstract][Full Text] [Related]
33. Oral pilocarpine: a review of its pharmacological properties and clinical potential in xerostomia. Wiseman LR; Faulds D Drugs; 1995 Jan; 49(1):143-55. PubMed ID: 7705213 [TBL] [Abstract][Full Text] [Related]
34. Pilocarpine in the prevention of postirradiation xerostomia. Lajtman Z; Krajina Z; Krpan D; Vincelj J; Borcić V; Popović-Kovacić J Acta Med Croatica; 2000; 54(2):65-7. PubMed ID: 11028111 [TBL] [Abstract][Full Text] [Related]
35. Efficacy of cevimeline vs. pilocarpine in the secretion of saliva: a pilot study. Brimhall J; Jhaveri MA; Yepes JF Spec Care Dentist; 2013; 33(3):123-7. PubMed ID: 23600983 [TBL] [Abstract][Full Text] [Related]
36. Comparison of the effects of pilocarpine and cevimeline on salivary flow. Braga MA; Tarzia O; Bergamaschi CC; Santos FA; Andrade ED; Groppo FC Int J Dent Hyg; 2009 May; 7(2):126-30. PubMed ID: 19416095 [TBL] [Abstract][Full Text] [Related]